Venous Thromboembolism Prophylaxis in Medical and Surgical ICUs in a Single University Hospital

Venous Thromboembolism Clinical Trial

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01851239
• Other study ID #: 1-2013-0002
• Status: Completed
• Phase: N/A
• First received: April 25, 2013
• Last updated: May 2, 2014
• Start date: February 2013
• Est. completion date: April 2014

Study information

• Verified date: May 2014
• Source: Yonsei University
• Contact: n/a
• Is FDA regulated: No
• Health authority: Korea: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

Venous thromboembolism(VTE) is the third most common cardiovascular complication among hospitalized patients, and can even cause death. VTE often occurs in intensive care patients and there had been many efforts to prevent such complication. The American College of Chest Physicians (ACCP) had published evidence-based clinical practice guideline for VTE prophylaxis.

This study focuses on how VTE prophylaxis is being performed in both medical and surgical ICUs in a single University hospital, and sees the differences in such prophylactic patterns.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1000
• Est. completion date: April 2014
• Est. primary completion date: July 2013
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 20 Years to 90 Years

Eligibility

Inclusion Criteria:

• ICU admitted patients

Exclusion Criteria:

• patients under 20 years old

Study Design

Observational Model: Case-Only, Time Perspective: Retrospective

Related Conditions & MeSH terms

• Thromboembolism
• Venous Thromboembolism

Locations

Country	Name	City	State
Korea, Republic of	Department of Anesthesiology and Pain Medicine, Severance Hospital, Yonsei University College of Medicine	Seoul

Sponsors (1)

Lead Sponsor	Collaborator
Yonsei University

Country where clinical trial is conducted

Korea, Republic of, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	number of patients prescribed with any measures of VTE prophylaxis in ICU	The object of this study is to see the percentage of ICU admitted patients prescribed with VTE prophylaxis, and analyze the adequacy of such prophylactic measure according to the international guideline. Moreover, difference between the VTE prophylaxis pattern of medical and surgical ICUs will also be seek for further analysis.	at the time of ICU admission an expected average of 5 months (When VTE prophylaxis for each patient is being ordered)	No